Evidence map›Paper›PMID 39745136›Full record

ReviewSmall (Weinheim an der Bergstrasse, Germany)2025

Optical Bionanosensors for Sepsis Diagnostics.

Christina Derichsweiler, Svenja Herbertz, Sebastian Kruss

Abstract readReview
In one paragraph

Review in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Optical Bionanosensors for Sepsis Diagnostics.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christina DerichsweilerBiomedical Nanosensors, Fraunhofer Institute for Microelectronic Circuits and Systems Finkenstrasse 61, 47057, Duisburg, Germany.ORCID 0009-0007-8126-8912
Svenja HerbertzBiomedical Nanosensors, Fraunhofer Institute for Microelectronic Circuits and Systems Finkenstrasse 61, 47057, Duisburg, Germany.ORCID 0000-0002-1348-4425
Sebastian KrussBiomedical Nanosensors, Fraunhofer Institute for Microelectronic Circuits and Systems Finkenstrasse 61, 47057, Duisburg, Germany.ORCID 0000-0003-0638-9822

Funding

"Center for Solvation Science ZEMOS"Deutsche Forschungsgemeinschaft Strategy-EXC 2033-390677874-RESOLVFraunhofer Internal Programs 038-610097German Federal Ministry of Education and Research BMBFGerman Federal Ministry of Education and Research BMBF and by the Ministry of Culture and Research of Nord Rhine-WestphaliaMinistry of Culture and Research of Nord Rhine-Westphalia IN-1-10B
6 · The paper itself

Abstract

Sepsis is a global health challenge, characterized by a dysregulated immune response, leading to organ dysfunction and death. Despite advances in medical care, sepsis continues to claim a significant toll on human lives, with mortality rates from 10-25% for sepsis and 30-50% for septic shock, making it a leading cause of death worldwide. Current diagnostic methods rely on clinical signs, laboratory parameters, or microbial cultures and suffer from delays and inaccuracies. Therefore, there is a pressing need for novel diagnostic tools that can rapidly and accurately identify sepsis. This review highlights advances in biosensor development that could ultimately lead to faster and more accurate sepsis diagnostics. The focus is on nanomaterial-based optical approaches that promise rapid diagnostics without the need for large equipment or trained personnel. An overview of sepsis is provided, highlighting potential molecular targets and the challenges they present for assay development. The requirements for an ideal point-of-care test (POC) are discussed, including speed, simplicity, and cost-effectiveness. Different nanomaterials suitable for various optical detection methods are reviewed and innovative nanosensors are discussed for sepsis diagnostics, focusing on chemical design and approaches to increase selectivity by multiplexing.

Indexed as

Biosensing TechniquesNanotechnologySepsisHumansNanostructuresPoint-of-Care Systemsbiosensorsdiagnosticsnanomaterialsopticalsepsis

Identifiers

PMID39745136
PMCPMC11855245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.